Form 4: CRL Executive Reports Routine Stock Disposition

Michael G. Knell, SVP of Finance and CAO at Charles River Laboratories, reported the disposition of 87 shares to cover tax obligations.

Summary

• Michael G. Knell, SVP of Finance and CAO, disposed of a total of 87 shares of Charles River Laboratories (CRL) common stock.
• The transactions occurred on May 26, 2026 (50 shares at $160.30) and May 27, 2026 (37 shares at $156.73).
• The shares were withheld by the company to satisfy tax withholding obligations related to the vesting of equity awards.
• Following these transactions, the reporting person maintains a beneficial ownership of 14,515 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and related to tax obligations rather than a strategic shift.

Positives

• The transaction was a routine administrative action related to tax withholding rather than a discretionary market sale.

Negatives

• Minor reduction in the executive's direct equity stake in the company.

Risks

• None identified; this is a standard regulatory filing for tax compliance.

Future Outlook

Not applicable; this is a historical record of a transaction.

Industry Context

StockSavvy.ai notes that routine tax-related share dispositions by corporate officers are standard industry practice and do not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for executive compensation and tax compliance in the life sciences sector.

Stakeholder Impact

• No material impact on shareholders or company operations.

Key Dates

Keywords

Charles River Laboratories, CRL, Form 4, Insider Trading, Tax Withholding, Equity Vesting